APA

Suzuki R., Hideshima T., Mimura N., Minami J., Ohguchi H., Kikuchi S., Yoshida Y., Gorgun G., Cirstea D., Cottini F., Jakubikova J., Tai Y., Chauhan D., Richardson P. G., Munshi N. C., Utsugi T. & Anderson K. C. (20150406). Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. : Leukemia.

Chicago

Suzuki R, Hideshima T, Mimura N, Minami J, Ohguchi H, Kikuchi S, Yoshida Y, Gorgun G, Cirstea D, Cottini F, Jakubikova J, Tai Y-T, Chauhan D, Richardson P G, Munshi N C, Utsugi T and Anderson K C. 20150406. Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. : Leukemia.

Harvard

Suzuki R., Hideshima T., Mimura N., Minami J., Ohguchi H., Kikuchi S., Yoshida Y., Gorgun G., Cirstea D., Cottini F., Jakubikova J., Tai Y., Chauhan D., Richardson P. G., Munshi N. C., Utsugi T. and Anderson K. C. (20150406). Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. : Leukemia.

MLA

Suzuki R, Hideshima T, Mimura N, Minami J, Ohguchi H, Kikuchi S, Yoshida Y, Gorgun G, Cirstea D, Cottini F, Jakubikova J, Tai Y-T, Chauhan D, Richardson P G, Munshi N C, Utsugi T and Anderson K C. Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. : Leukemia. 20150406.